表紙
市場調査レポート

世界の新生児スクリーニング市場:業界分析と市場予測

Global Newborn Screening Market - Industry Analysis And Market Forecast (2015-2020)

発行 Mordor Intelligence LLP 商品コード 319330
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
世界の新生児スクリーニング市場:業界分析と市場予測 Global Newborn Screening Market - Industry Analysis And Market Forecast (2015-2020)
出版日: 2016年01月01日 ページ情報: 英文
概要

代謝性疾患や遺伝性疾患が様々な形で乳児の通常の身体的、精神的発達を妨げることがあります。今や簡単な血液検査によって、新生児が最終的に問題となる症状をもっているかどうかを判定することができます。早期に診断し適切な治療をすることで、その後の発達に大きな違いをもたらすことがあります。

当レポートでは、世界の新生児スクリーニング市場について調査し、スクリーニングされる一般的な疾患、検査の種類、技術概要などをまとめています。

第1章 概要

第2章 スクリーニングされる最も一般的な疾患

  • PKU
  • 先天性甲状腺機能低下症
  • ガラクトース血症
  • 鎌状赤血球病
  • ビオチニダーゼ欠損
  • 先天性副腎過形成
  • メープルシロップ尿症
  • チロシン血症
  • 嚢胞性線維症
  • MCAD欠損
  • トキソプラズマ症
  • 聴覚スクリーニング

第3章 新生児スクリーニング市場のカテゴリー

  • 検査の種類
    • 血液検査
    • 聴覚検査
    • 先天性心疾患検査
    • パルスオキシメトリ

第4章 新生児スクリーニング市場:技術別

  • タンデム質量分析
  • ヘモグロビン電気泳動検査
  • 免疫測定および酵素アッセイ
  • 聴覚スクリーニング
  • パルスオキシメトリスクリーニング

第5章 免責事項

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The Global Newborn Screening market is expected to reach USD XX million by 2020 growing at a CAGR of XX%. The newborn Screening is performed to screen infants after birth for detection of any health conditions or diseases that can be fatal but are not depicted during birth. The newborn screening tests are basically evaluation of metabolites and blood samples. The newborn screening tests varies according to different country jurisdictions. In many areas newborn screening test includes screening for hearing loss, congenital heart disease etc. The major diseases screened are sickle cell disease, cystic fibrosis, newborn hearing loss, congenital hypothyroidism, phenyl ketone urea, congenital heart disease, and others.

The presence of federal bodies for organizing awareness programmes, increasing awareness in developed countries, technological advancements in healthcare, and increasing array of newborn diseases are propelling the growth of this market. However, unawareness in developing countries, lack of trained professionals and socio-economic barriers in developing countries are posing restraint to the growth of this market.

The global newborn screening market have been segmented based on technology, product, and test type. The segmentation based on technology have been subdivided into tandem mass spectrometry, DNA based assay, enzyme and immunoassays, electrophoresis, hearing screening technology, and pulse Oximetry technology. The segmentation based on product sub-divided into newborn disorder screening instruments, hearing screening devices and accessories, Pulse Oximetry, and Reagents and assay kits. The segmentation based on Test Type have been sub-divided into critical congenital heart disease test, hearing screening test, and dry blood spot test.

The global Newborn screening test Market have been segmented based on geography as North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. The segmentation on North America discusses different market trends, and market size of newborn screening tests in USA, Canada and Mexico. The Europe segment have been further subdivided into UK, France, Italy, Germany, Benelux, Scandinavia, Spain and Portugal. The segmentation on Asia-Pacific have been subdivided into China, Japan, India, South Korea, Australia, and New Zealand. The Middle-east & North Africa segment includes GCC, Egypt, and others. The South America region includes Brazil, Argentina, Colombia and others.

The technological advancement in healthcare and more physicians advising newborn screening test and increasing awareness amongst people are some crucial factors that are propelling the growth of this market. Amongst technology being used tandem mass spectrometry is expected to have the fasted growth rate during the forecast period. The Dry blood spot test has the largest market share amongst segmentation by test type. The key players in this market are Agilent Technologies, AB Sciex LLC, Covidien PLC, PerkinElmer Inc., Trivitron Healthcare, Bio-rad Laboratories, Masimo Corporation, Natus Medical, Waters Corporation and GE Healthcare.

Key deliverables of the study:

  • Market Definition for the specified topic along with identification of key drivers and restraints for the market.
  • Market analysis for the Global Newborn Screening test Market, with region specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
  • Identification and analysis of the Macro and Micro factors that affect the Global Newborn Screening test Market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

Introduction

  • Study deliverables
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and Forecast period years
  • General Study Assumptions

Research Methodology

  • Introduction
  • Analysis Methodology
  • Econometric Forecast Model
  • Research Assumptions

Executive Summary

Key Inferences

Market Overview and Industry trends

  • Current Market Senario
  • Newborn Screening test Applications
  • Technology Overview
  • New Developments
  • Industry Value chain analysis
  • product Life cycle analysis
  • Product Benchmarking
  • Investment Analysis
  • Porter's Five Forces

Drivers, Restraints, Opportunities, and challenges Analysis

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Market Challenges

Global Newborn Screening Market segmentation

  • Introduction
  • Segmentation by Technology
  • Segmentation by Product
  • Segmentation by test type

Market segmentation by Geography - North America

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Middle-East and North Africa
  • South America

Competitive Landscape

  • Merger and acquisition analysis
  • New Product Launches
  • Agreements, Collaborations and Partnerships

Key Vendor Analysis

  • Agilent Technologies
  • AB Sciex LLC
  • Covidien PLC
  • PerkinElmer Inc.
  • Trivitron Healthcare
  • Bio-Rad Laboratories
  • Masimo Corporation
  • Natus Medical
  • Waters Corporation
  • GE Healthcare

Analyst outlook for Investment opportunities

Future Outlook of the market

Back to Top